Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | RXRG | P48443 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | DNMT1 | P26358 | 3/20 | 0.30 |
| ▸ | MAT2A | P31153 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12716611 | 0.94 | KDM4E (0.38) | ALDH1A1MAPTMAPK1NPSR1KDM4E | |
| SCHEMBL12716581 | 0.92 | ALDH1A1 (0.38) | ALDH1A1MAPTMAPK1NPSR1KDM4E | |
| SCHEMBL12716539 | 0.91 | KDM4E (0.41) | ALDH1A1MAPTMAPK1NPSR1KDM4E | |
| SCHEMBL18267256 | 0.89 | DNMT1 (0.32) | ALDH1A1L3MBTL1KCNH2DNMT1 | |
| SCHEMBL12716594 | 0.88 | ALDH1A1 (0.36) | ALDH1A1MAPTMAPK1NPSR1KDM4E | |
| SCHEMBL12716586 | 0.86 | ALDH1A1 (0.37) | ALDH1A1MAPTMAPK1NPSR1KDM4E | |
| SCHEMBL12716576 | 0.86 | ALDH1A1 (0.35) | ALDH1A1MAPTMAPK1NPSR1KDM4E | |
| SCHEMBL9920653 | 0.86 | ALDH1A1 (0.36) | ALDH1A1MAPTMAPK1NPSR1KDM4E | |
| SCHEMBL12716610 | 0.85 | MAPT (0.36) | ALDH1A1MAPTMAPK1NPSR1KDM4E | |
| SCHEMBL12716580 | 0.85 | ALDH1A1 (0.36) | ALDH1A1MAPTMAPK1NPSR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7923129-B2 | extremely high efficiency and a high luminance and has an extremely high durability; 2-pyrenylcarbazoles; blue | CANON KABUSHIKI KAISHA (JP) | 2011-04-12 | — | — | US | disclosed |
| US-7923129-B2 | extremely high efficiency and a high luminance and has an extremely high durability; 2-pyrenylcarbazoles; blue | CANON KABUSHIKI KAISHA (JP) | 2011-04-12 | — | — | US | disclosed |
| US-20080131731-A1 | CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-06-05 | — | — | US | disclosed |
| US-20080131731-A1 | CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080131731-A1 | CARBAZOLE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | OXA1L, CYP2C19, PPOX | ALDH1A1 30/4885MAPT 3175/4885MAPK1 1958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.